Emerging Tech Forum

The Atlantic Nano Forum presents

Commercializing Nanotechnology for Biopharma Applications

with a presentation by Dr. Michael Helmus

Sr. Vice President
Biopharma, Advance Nanotech

Date:	Thursday, September 28, 2006
Time	Registration begins at 4:00 PM; program begins at 4:30 PM
Cost:	Attendance is free
Location:	Offices of Buchanan Ingersoll & Rooney 1737 King Street, Suite 500 Alexandria, VA Please send RSVP to nanotech@bipc.com Directions

Nanofabricated systems have the potential to enable new diagnostic and therapeutic applications of medical technology for devices and pharmaceuticals. The ability to demonstrate feasibility at early stages of research and move from bench to bedside has significant barriers, particularly when new technology is implemented. Emerging collaborations between academic and industrial partners and the focus of technology platforms on clinical applications will provide the necessary focus to bring bionanotechnology across the "valley of death" into the clinical setting, meaning nanomedicine will become a reality. The talk will address the following:

Why Nanotechnology
The Bridge to Commercialization
Proof of Principle in a Clinically Relevant Setting
Drivers for Development
Cost Containment, New Therapies, New Diagnostics and Point of Care Medicine
Societal Concerns
Regulatory - Safety Testing esting
Case Study: Drug Eluting Stents
Intellectual Property

Dr. Michael Helmus
Sr. Vice President of Biopharma, Advance Nanotech
Dr Dr. Michael Helmus served as the vice president of advanced biomaterials at Boston Scientific before joining Advance Nanotech as senior vice president of biopharma. Prior to that, Dr Dr. Helmus held leadership positions with organizations including Edwards Lifesciences, Baxter CVS, Pfizer and Arthur D. Little. Dr Dr. Helmus holds a Ph.D. and an M.S. degree in biomedical engineering from Case Western Reserve University and a B.S. in metallurgy and materials science from Lehigh University.

Dr. Helmus' expertise includes the identification and acquisition of new technologies, implementation and management of research and development programs and intellectual property development and management. In the courseof his career career, Dr. Helmus has issued 27 U.S. patents, authored more than 80 publications and presentations concerning biomaterials, medical devices and drug delivery technology and market assessments. He serves on the editorial board of the Journal of Biomedical Materials Research and the advisory boards of the Center for Modular Microsystems (CM2); the New Jersey Center for Biomaterials; University of Massachusetts-Boston; and the Department of Biomedical Engineering, Case Western Reserve University. He teaches a course in biomaterials in the design of medical devices at Worcester Polytechnic Institute and his book, "Biomaterials in the Design and Reliability of Medical Devices," was published in 2003.

With Participation From

If you do not wish to receive future communications from Emerging Tech Forum, please click here to unsubscribe, and we will immediately remove your name from our mailing list.